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1. Introduction 
Fibrinogen is composed of three pairs of polypeptide 
chains: o(A), /3(B), and y [ 1,2] . Fibrinopeptides A 
and B are cleaved off the a(A) and P(B) chains respecti- 
vely by thrombin. The resulting product is fibrin [3,4]. 
Sulfitolysis of fibrinogen results in the cleavage of the 
disulfide bridges [5] , and the resulting S-sulfo chain 
derivatives have been separated by paper [ 51, starch 
gel electrophoresis [6] and column chromatography 
[S, 71. More recently, the S-sulfo chain derivatives 
from bovine [8] and human [9] fibrinogen have been 
isolated on carboxymethyl cellulose using a stepwise 
[8] and gradient [9] sodium acetate buffer system. 
In this study, the S-carboxymethyl derivatives of 
the three human fibrinogen chains were separated on 
carboxymethyl cellulose, with an exponential sodium 
acetate buffer gradient, and a concomitant pH gradient, 
in the presence of 8 M urea. Each chain was character- 
ized and identified by N-terminal amino acid analysis, 
polyacrylamide gel electrophoresis, fingerprinting, and 
amino acid analysis. 
2. Materials and methods 
Fibrinogen: A 3.67% solution of human fibrinogen, 
98% clottable [lo], in 0.3 M NaCl was lyophylized. 
Dithiothreitol (DTT) [ 11, 121 was obtained from 
P-L Biochemicals Inc. Milwaukee, Wis. Lot No. 72-17. 
Iodoacetic acid (Kebo) was recrystallized 5X from 
CC&, and stored in the dark. This product was called: 
Carrier. 
2-3 H-Iodoacetic acid (Radiochemical Centre, 
North-Holland Publishing Con1pan.v Amsterdam 
Amersham, England) Lot No. B 10, specific activity: 
50-l 50 mCi/mmole, was diluted appropriately with 
carrier iodoacetic acid before use. 
3H-Iodoacetic acid-carrier mixture was prepared 
fresh by mixing 4 ml of 1 M iodoacetic acid carrier 
(186 mg/mI of 0.1 N NaOH) with 6 ml of 2-j H-iodo- 
acetic acid (1 mCi/ml of 0.1 N NaOH). 
Carboxymethyl cellulose (CM-52) was precycled 
as recommended by the manufacturer (H. Reeve 
Angel and Co., London, England). 
Radioactivity measurements were performed with 
a Beckman liquid scintillation system (CPM 200). 
N-Terminal sequence amino acid analysis: The 
three stage phenylisothiocyanate method of Edman 
was used [ 13- 161 using phenylisothiocyanatF-34 S 
as the coupling agent [ 171. This procedure permitted 
the analysis to be performed on 2-5 mg quantities 
of each chain. 
Amino acid analysis [ 181 was performed on a 
Technicon autoanalyzer. Caution was exercised in 
evacuating the samples thoroughly in preparation for 
22 hr acid hydrolysis in an atmosphere of Nz . This in- 
sured minimal destruction of S-carboxymethyl cys- 
teine. 
Polyacrylamide gel electrophoresis was carried out 
at acid pH in a disc electrophoresis analytical apparatus 
(Shandon) as described [ 191, with slight modifications. 
A 7.5% gel solution was used, and the samples were 
electrophoresed for 2.5 hr. 
Trypsinolysis and fingerprinting were performed on 
thin-layer plates (Whatman CC-41) as described [20], 
using Trypsin-TPCK (Worthington) with a 12 hr di- 
gestion period. 
Antibody production and purification: Antibodies 
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Fig. 1. Chromatographic profile of human S-carboxymethyl fibrinogen on Whatman cellulose (CM-5 2), using a sodium acetate and 
pH gradient, in the presence of 8 M urea. (- ) (A) 254 mm. (- - -) cpm X 105. Polyacrylamide gel electropherograms, per- 
formed in 5% acetic acid, appear directly above each peak. The arrows indicate the origin. The electropherogram to the far left, con- 
taining three major components, is typical for S-carboxymethyl fibrinogen prior to chromatography. 
to the individual chains were elicited in rabbits by 
routine foot-pad immunization and purified as de- 
scribed [21 J using BrCN activated Sephadex [22] for 
the preparation of the immunoadsorbents. 
All other chemicals were reagent grade. 
2.1. Reduction and S-carboxymethylation 
The lyophylized, salt containing fibrinogen product 
(1.168 g, containing 760 mg pure fibrinogen) was 
dissolved in 45 ml of deareated 8.4 M guanidine chlor- 
ide (Kebo) pH 8.5. Once the product was in solution, 
the pH was readjusted to 8.5 with 1 N NaOH. The 
mixture was incubated at 40” for 1 hr. DTT (97 mg) 
in 1 ml of deaerated distilled water was added (10 moles/ 
mole disulfide). The pH was adjusted to 8.8 f 0.1 with 
1 N NaOH. The vessel was flushed with nitrogen, cap- 
ped, and incubated at ambient temperature for 1.5 hr. 
The vessel was wrapped in aluminium foil and carboxy- 
methylation commenced by the addition of 7.8 ml of 
2-3H-iodoacetic acid-carrier mixture (5 moles/mole 
DTT). The pH usually dropped below 6.0, and was 
immediately adjusted to 8.3 f 0.1 with 2 N NaOH. 
The reaction was allowed to proceed for precisely 15 
min. Glacial acetic acid was added to a final concen- 
tration of 5%, and the sample applied directly to a 
Sephadex G-25 (Pharmacia) column 5 X 70 cm, pre- 
viously equilibrated with 5% (v/v) acetic acid. The 
column was wrapped in aluminium foil, and developed 
at a flow rate of 150 ml/hr. The carboxymethylation 
reaction and subsequent chromatography were carried 
out in the dark to avoid oxidation of iodide to iodine, 
thereby minimizing modification of tyrosine, histidine 
and tryptophan residues. Complete separation of 
salts and excess reagents from the protein was attained. 
The sample was lyophylized. The yield was quantita- 
tive. This product was called: CM-fibrinogen. 
2.2. Chromatography on CM-cellulose 
The buffers utilized in this system were always pre- 
pared fresh. A cclumn of cellulose 2.5 X 15 cm was 
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Table 1 
Amino acid composition of S-carboxymethyl fibrinogen (human) and its S-carboxymethyl chain derivatives (@moLes/mg)*. 
CM- Peak 1 Peak 2 Peak 3 Peak 4 
Residue fibrinogen 7 chain p (B) chain a (A) +? chain OL (A) chain 
CM-W 0.127 0.142 0.139 0.102 0.071 
Asp 1.011 1.031 1.035 0.975 0.801 
Thr 0.466 0.440 0.339 0.493 0.517 
Ser 0.615 0.412 0.458 0.836 0.875 
Glu 0.989 0.967 1.033 0.936 0.814 
pro 0.397 0.266 0.377 0.507 0.455 
ClY 0.761 0.617 0.699 0.865 0.819 
Ala 0.412 0.476 0.412 0.304 0.279 
Val 0.387 0.307 0.426 0.419 0.342 
CYSD 0 0 0 0 0 
Met 0.176 0.159 0.257 0.152 0.117 
Be 0.332 0.432 0.285 0.277 0.209 
Leu 0.479 0.484 0.479 0.470 0.363 
Tyr 0.269 0.335 0.316 0.129 0.106 
Phe 0.251 0.296 0.172 0.221 0.224 
Try - - _ - - 
LYS 0.608 0.580 0.522 0.525 0.474 
His 0.169 0.152 0.107 0.142 0.165 
Arg 0.420 0.198 0.408 0.538 0.467 
* Represents an average of 4 analyses on two separate products. 
equilibrated with starting buffer (0.025 M sodium 
acetate-8 M urea, pH 4.8) at a flow rate of 12-14 
ml/hr at ambient temperature. CM-fibrinogen (320 mg) 
was dissolved in approximately 6 ml of starting buffer, 
and applied on top of the cellulose bed with several 
2 ml washes. The column was developed with a gradient 
formed by a Technicon ‘autograd’. Chambers l-3 con- 
tained 400 ml of starting buffer, chambers 4-6 con- 
tained 400 ml of: 0.175 M sodium acetate-8 M urea, 
pH 5.2 buffer. The effluent was collected in 5.5 ml 
fractions and the protein zone monitored by automa- 
tic absorbance measurements at 254 nm. (LKB Uvicord 
II, and LKB Recorder). The peaks were pooled as indi- 
cated in the chromatographic profile (fig. 1). Salts were 
removed by extensive dialysis against distilled, deionized 
water (alkaline with NHa to minimize precipitation). 
The protein solution was lyophilized. For analytical 
purposes, each peak fraction from several runs (loo- 
150 mg) was rechromatographed on a fresh column 
under the same conditions and pooled sharply. 
3. Results and discussion 
The yield (total protein) from a typical chromato- 
graphy was about 85%. The S-carboxymethyl products 
were insoluble in water, but soluble in 10% acetic acid 
or 8 M urea solutions. The amino acid analysis (table 
1) revealed that all disulfide bridges were reduced and 
carboxymethylated. No side reactions, such as the 
carboxymethylation of the e-amino group of lysine 
or the oxidation of methionine to sulfoxides were 
observed. Fig. 1. is a typical chromatographic profile. 
Radioactivity measurements were concurrent with 
the carboxymethyl cysteine content calculated from 
the amino acid analyses (table 1). Polyacrylamide gel 
electrophoresis (fig. 1) showed peaks 1,2 and 4 to be 
virtually homogeneous. The width of the electrophor- 
etic band of peak 1 indicated a minor heterogeneity, 
probably of the type recently described for the y 
chain [8] . Peak 3 contained 4 molecular species, one 
of which corresponded to peak 4. 
N-Terminal amino acid analysis on CM-fibrinogen 
compared well with that of native fibrinogen. The 
Ala + Asp/Tyr ratio was 0.85 7 0.1 /l .O. Both products 
contained traces (2-570) of glutamic acid and glycine. 
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Table 2 
N-Terminal amino acids. 
Peak No. Chain ~-Terminal residues 
identification 
Step 1 Step 2 
1 ‘y 
2 8 (B) 
3 CY (A) +? 
4 a (A) 
~._ 
Tyr Val 
(Gly, Glu, Asp, Ala)* 
None None 
Ala Asp 
21% 15% 9% ** (Ser)* 
(Asp, Glu, GUY) 
Ala Asp 
22% 14% 14% ** (Ser)* 
(Asp, Glu, Gly) 
* Traces (less than 5%) 
** Percent of Ala. 
The N-terminal sequence analysis (table 2) confirmed 
the homogeneity of peak 1,2 and 4, and identified 
them as: y, /3 (B) and OL (A) chains respectively [23] . 
The pyro~ut~yl ~-terminus on the /3 (B) chain does 
not permit coupling with phenylisothiocyanate. Peak 
II- -- 
+ 
- 
+ 
3, aIthou~ heterogeneous in polyac~l~ide gel 
electrophoresis, displayed the same N-terminal amino 
acid profile as peak 4. 
From the N-terminal sequence analysis (table 2) 
and from the amino acid analysis data, it was postu- 
lated that peak 3 might in effect contain structural 
variants of the CC (A) chain (peak 4). This being the 
case, in the fingerprint profiles, peak 3 should exhibit 
substantial similarities to peak 4. This is precisely what 
was observed (fig. 2, A and D). Furthermore, immu- 
nologic studies performed with the double diffusion 
technique of Ouchterlony showed that antibodies 
against peak 4 (a! (A)) reacted with immunologic iden- 
tity between peak 3 (a (A) +?) and peak 4 (a! (A)). 
Extensive physico-chemical and immunologic 
studies characteriz~g the three chains, including the 
‘variants’ in peak 3, are in progress. 
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Fig. 2. Fingerprint profiles of the tryptic digests of the four peak components shown in fig. 1. Electrophoresis (++). chromato- 
graphy ($). A = peak 4 (@(A) chain); B = peak 2 (P(B) chain); C = peak 1 (y chain); D = peak 3 (ol(Af +? chain(s)). The plates 
were developed with ninhydrin. Each spot is marked according to intensity. The spots markedy appear yellow, and are usually 
indicative of prolinc and/or glycine. They serve as excellent landmarks for purposes of comparison. x = origin. 
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